Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5550675 | 0.82 | L3MBTL1 (0.54) | MAPTHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL5546266 | 0.79 | EGFR (0.46) | MAPTHPGDALDH1A1SMN1; SMN2EGFR | |
| SCHEMBL5550802 | 0.71 | MAPT (0.56) | MAPTHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL5547460 | 0.70 | ALOX5 (0.46) | MAPTHPGDALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL5550024 | 0.70 | MAPT (0.55) | MAPTHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL5550840 | 0.68 | KMT2A (0.47) | MAPTHPGDALDH1A1TRPA1MEN1 | |
| SCHEMBL5551976 | 0.67 | MAPT (0.46) | MAPTHPGDALDH1A1SMN1; SMN2TRPA1 | |
| SCHEMBL5550036 | 0.66 | KMT2A (0.45) | MAPTHPGDALDH1A1TRPA1MEN1 | |
| SCHEMBL5550706 | 0.66 | ALDH1A1 (0.50) | MAPTALDH1A1SMN1; SMN2TRPA1MEN1 | |
| SCHEMBL1241022 | 0.65 | SOS1 (0.54) | MAPTHPGDALDH1A1SMN1; SMN2TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002000649-A9 | SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS | ASTRAZENECA AB (SE) | 2007-09-20 | — | — | WO | disclosed |
| CN-1496364-A | Substituted quinazoline derivatives and their use as inhibitors | — | 2004-05-12 | — | — | CN | disclosed |
| EP-1299381-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS | AstraZeneca AB (SE) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002000649-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS | ASTRAZENECA AB (SE) | 2002-01-03 | — | — | WO | disclosed |